Shukla Sath
Spero Therapeutics, Inc. · CEO & President
Shukla Sath is listed in filings as CEO & President at Spero Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 5, 2025, including sale activity. Recent filings connect the profile to Spero Therapeutics, Inc. (SPRO). The current snapshot covers public activity from Aug 6, 2024 to Feb 5, 2025. Reported amounts are shown as $4.8K to $33.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4.8k6.1k shares | SellFeb 5, 2025 | $0.78 | $2.90 | |
| $83k106.4k shares | SellFeb 5, 2025 | $0.78 | $2.90 | |
| $33k42.8k shares | SellFeb 5, 2025 | $0.78 | $2.90 |